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A Comparative Study of Clinical Symptoms and Treatment 
Outcomes of Acute Bacterial Prostatitis According to Urine Culture 
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Department of Urology, Ewha Womans University School of Medicine, Seoul, Korea 
Purpose: Because acute bacterial prostatitis (ABP) is an urgent condition of the prostate 
but prostatic massage is contraindicated at the onset of ABP, clinical symptoms and 
urine tests are used for diagnosis. In this study, we compared the clinical symptoms 
and treatment outcomes of patients with negative urine culture results, to whom only 
empirical antibiotics were administered, with those of patients with positive urine cul-
ture results. 
Materials and Methods: Patients were divided into two groups according to the results 
of urine culture. Then, the clinical symptoms and course of each group were analyzed. 
In addition, age, symptoms, antibiotics, mean inpatient and outpatient length of treat-
ment, and the treatment outcome of each group were also analyzed.
Results: Of the total 144 patients, the positive urine culture group consisted of 51 pa-
tients (35.4%) and the most frequent bacterial strain causing ABP was reported to be 
Escherichia coli. Fever and storage symptoms were significantly more common in the 
positive urine culture group than in the negative urine culture group (p=0.031 and 
0.047, respectively). Only inpatient treatment was significant longer in the positive 
urine culture group than in the negative urine culture group (p＜0.05). The mean length 
of treatment of inpatients was 4.8±2.6 days and 6.2±2.9 days in the two groups, 
respectively. No sequelae such as prostatic abscess or chronic prostatitis were found 
in either group. 
Conclusions: In the treatment of ABP, the use of empirical antibiotics can be expected 
to have sufficient effects regardless of bacterial culture. However, it is hard to determine 
the causative bacteria of ABP by urine culture results only.
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INTRODUCTION 
Acute bacterial prostatitis (ABP) is a rare disease that 
makes up only 5% of prostatitis, and it is possible to diag-
nose the disease by clinical symptoms. In addition, it is also 
known as being a rather easy disease to cure [1]. The most 
frequent bacteria causing ABP have been reported to be 
Escherichia coli ( E. coli), and Enterococcus, Proteus, 
Pseudomonas, Klebsiella, and Serratia species have also 
been reported [2-4]. Antimicrobial treatment should be ini-
tiated immediately in patients with ABP after blood and 
urine cultures have been obtained.
　Initially, parenteral administration of high doses of bac-
tericidal antibiotics, such as a broad-spectrum penicillin 
derivative, a third-generation cephalosporin with or with-
out an aminoglycoside, or a quinolone, are required until 
the fever and other signs and symptoms of infection 
subside. After initial improvement, a switch to an oral regi-
men, a quinolone, is appropriate and should be prescribed 
for at least 4 weeks. In less severe cases, a quinolone may 
be given orally for 2 to 4 weeks [5]. 
To treat ABP effectively, we should administer empirical 
antibiotics first and then decide what to use by the results 
of antibiotics sensitivity tests of urine culture. If the urine Korean J Urol 2011;52:119-123
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TABLE 1. Characteristics of the disease of 145 patients with 
acute bacterial prostatitis
Negative   Positive 
urine culture urine culture p-value
(n=93) (n=51)
Symptoms
   Fever (%) 59 (64.3) 39 (75.0) 0.031
a
   Pain, any kind (%) 28 (30.6) 20 (38.5) 0.832
a
   Dysuria (%) 60 (57.3) 31 (59.6) 0.735
a
   Urinary retention (%) 13 (15.2)   8 (17.3)  0.732
a
   Voiding symptoms (%) 51 (55.3) 28 (55.8) 0.843
a
   Storage symptoms (%) 24 (25.8) 24 (46.2) 0.047
a
Admission rate (%) 30 (32.3) 35 (67.3) 0.069
b
Manipulation rate (%) 11 (10.3) 16 (30.8) 0.098
b
Mean pyuria grade 1.8±5.8 2.8±7.2 0.175
c
Total length of 18.7±10.5 19.9±11.5 0.517
b
 treatment (d)
   Inpatient 4.8±2.6 6.2±2.9 0.043
b
   After discharge 13.9±11.3 13.7±11.1 0.207
b
Outpatient only 16.8±10.8 17.3±10.9 0.425
b
a: chi-square test, 
b: Student’s t-test, 
c: Wilcoxon rank sum test 
culture test is negative, however, we can only administer 
empirical antibiotics. 
In this study, we compared the clinical symptoms and 
treatment outcomes of patients with negative urine cul-
ture results, to whom only empirical antibiotics were ad-
ministered, with those of patients with positive urine cul-
ture results. 
MATERIALS AND METHODS
A retrospective analysis of 144 patients diagnosed as hav-
ing ABP between 2005 and 2009 was performed. Patients 
were divided into two groups, the negative urine culture 
group (group 1) and the positive urine culture group (group 
2), according to the results of urine culture, and the charac-
teristics and antibiotic use of each group were analyzed. In 
addition, the microbiological spectrum and antibiotics sus-
ceptibility of each group were analyzed.
ABP was diagnosed in all patients according to clinical 
features (fever, problems with voiding) and the results of 
laboratory tests. Patients with ABP symptoms and a pos-
itive urine culture result, or those with compatible signs 
but with a negative urine culture result, were selected. 
Because there are a few reports showing that chronic dis-
eases (e.g., diabetes mellitus, hypertension) do not influ-
ence ABP, patients with chronic diseases were included in 
this study [6]. Patients with other causes of urinary tract 
infection (e.g., pyelonephritis, sexually transmitted in-
fection) and those who had a history of prostate cancer at 
the time of diagnosis were excluded. Patients with compat-
ible signs but negative urine culture results due to previous 
antibiotics use were excluded. In the case of patients who 
were treated in another hospital before, we used the urine 
culture result of the previous hospital.
Clinical symptoms and a detailed history were taken to-
gether with a physical examination and laboratory 
investigations. Treatment parameters and microbiology 
results were documented.
The clinical features considered were as follows: present-
ing symptoms (fever, pain, dysuria, urinary retention, 
voiding symptoms, storage symptoms), laboratory inves-
tigations (urine analysis, urine culture), and treatment pa-
rameters (antibiotic treatment, mean length of treat-
ment). Voiding symptoms (e.g., weak stream, abdominal 
straining, hesitancy, incomplete bladder emptying, inter-
mittency, and terminal dribbling) and storage symptoms 
(e.g., frequency, nocturia, and urgency or urge incon-
tinence) were checked by patients’ history taking. Many 
patients complained about dysuria, so we investigated 
them separately. Urinary retention was defined as more 
than 400 ml of residual urine. Fever was defined as body 
temperature ＞37.5
oC. Pyuria was defined as ＞4 white 
blood cells (WBCs)/high power field. We divided patients 
into 5 groups according to urine WBC results. Urine WBC 
count of 0-2 was considered grade 1, WBC count of 3-5 was 
considered grade 2, WBC count of 6-10 was considered 
grade 3, WBC count of 11-20 was considered grade 4, and 
higher WBC counts were considered as grade 5. We then 
analyzed the mean pyuria grade. Patients with bacteriuria 
in their urine were placed into group 2. Microbial suscepti-
bility was determined by using the agar diffusion method 
according to the guidelines of the National Committee for 
Clinical Laboratory Standards. Results were analyzed ac-
cording to two subgroups: urine culture negative and urine 
culture positive. Results were analyzed by using the 
chi-square test, Student’s t-test, and Wilcoxon rank sum 
test. A p-value＜0.05 was considered statistically signifi-
cant. 
RESULTS
Group 1 consisted of 93 patients (64.6%) and group 2 con-
sisted of 51 patients (35.4%). The mean age of each group 
was 51.3±14.2 years (range, 23-75 years) and 56.6±16.7 
years (range, 20-86 years), respectively.
Fever was the most common clinical symptom in both 
groups. Only fever and storage symptoms were sig-
nificantly higher in group 2 than in group 1 (p=0.031 and 
0.047, respectively). For the mean length of treatment, only 
inpatient treatment was significantly longer in patient 
group 2 than in group 1 (p＜0.05). Concerning other fea-
tures, we found no statistically significant differences 
(Table 1).
　Twenty-eight patients in group 1 and 17 patients in group 
2 received antibiotics single therapy. Quinolone was used 
most often: 13 patients (46.4%) in group 1 and 6 patients 
(35.3%) in group 2. Combination therapy, on the other 
hand, was received by 65 patients in group 1 and 34 patients 
in group 2. The combination of a third-generation cepha-
losporin＋aminoglycoside was used most often: 33 pa-
tients (50.8%) in group 1 and 10 patients (29.4%) in group Korean J Urol 2011;52:119-123
A Comparative Study of Acute Bacterial Prostatitis 121
TABLE 2. Distribution of prescribed antimicrobial agents in 
acute bacterial prostatitis patients
Negative Positive
Antimicrobial agent urine culture urine culture
  (n=93) (n=51)
Single therapy
   Penicillin (%)   0 (0.0)   0 (0.0)
   1st generation cephalosporin (%)   0 (0.0)   1 (5.9)
   2nd generation cephalosporin (%)   4 (14.3)   3 (17.7)
   3rd generation cephalosporin (%)   4 (14.3)   4 (23.5)
   Quinolone (%) 20 (71.4)   8 (47.1)
   Macrolide (%)   0 (0.0)   1 (5.9)
   Total (%) 28 (30.1)  17 (33.3)
Combination therapy
   2nd generation cephalosporin   8 (12.3)   8 (23.5)
    ＋aminoglycoside (%) 
   3rd generation cephalosporin 33 (50.8) 10 (29.4)
    ＋aminoglycoside (%)
   3rd generation cephalosporin    9 (13.8)   7 (20.6)
    ＋quinolone (%)
   Quinolone＋aminoglycoside (%) 15 (23.1)   6 (17.6)
   Carbapenem＋aminoglycoside (%)   0 (0.0)   1 (2.9)
   Carbapenem＋quinolone (%)   0 (0.0)   1 (2.9)
   Glycopeptide＋aminoglycoside (%)   0 (0.0)   1 (2.9)
   Total 65 (69.9)  34 (66.6)
TABLE 3. Microbiological spectrum from urine culture of 
patients with acute bacterial prostatitis
Without With 
Total (%)
manipulation (%) manipulation (%)
Negative 82 (70.1) 11 (40.7) 93 (64.6)
Positive 35 (29.9) 16 (59.3) 51 (35.4)
　E. coli 19 (54.3)   9 (56.3) 28 (54.9)
　E. faecalis   4 (11.4)   2 (12.4)   6 (11.8)
　S. aureus   4 (11.4)   1 (6.3)   5 (9.8)
　Proteus   3 (8.6)   0   3 (5.9)
　P. aeruginosa   1 (2.9)   3 (18.7)   4 (7.8)
　K. pneumoniae   4 (11.4)   1 (6.3)   5 (9.8)
TABLE 4. Antibiotic susceptibility of pathogens isolated in patients with acute bacterial prostatitis
E. coli  E. faecalis  K. pneumoniae  S. aureus  Other 
(n=28) (n=6) (n=5) (n=5) pathogens (n=7)
Ampicillin (%)   9 (32.1)  2 (33.3) 0 (0.0) NT   3 (37.5)
2nd generation cephalosporin (%) 23 (82.1) NT   4 (80.0) NT   4 (50.0)
3rd generation cephalosporin (%) 25 (89.3) NT   3 (60.0) NT   6 (75.0)
Ciprofloxacin (%) 20 (71.4)  5 (83.3) NT 2 (40.0)   6 (75.0)
Amikacin (%) 24 (85.7) NT     5 (100.0) NT   7 (87.5)
Clindamycin (%) NT NT NT 2 (40.0) 0 (0.0)
Gentamicin (%) 23 (82.1) NT     5 (100.0) 2 (40.0)   1 (12.5)
Teicoplanin (%) NT 0 (0.0)  NT   5 (100.0) 0 (0.0)
Imipenem (%)   28 (100.0) NT     5 (100.0) NT   3 (37.5)
Vancomycin (%) NT 0 (0.0) NT   5 (100.0)   2 (25.0)
NT: not tested 
2 (Table 2). In group 2, there were no cases of antibiotics 
replacement because of resistance. 
　When the groups were classified according to the pres-
ence or absence of prior manipulation, we found that in 
about 18.8% (27/144) of patients, ABP was secondary to ma-
nipulation of the lower urinary tract. Regardless of manip-
ulation, it appeared that 93 patients (64.6%) showed neg-
ative urine culture results and 51 patients (35.4%) showed 
positive urine culture results. E. coli was the most common 
causative bacteria and no distinct difference in the type of 
pathogens was noted. Enterococcus, Staphylococcus, 
Proteus, Pseudomonas, and Klebsiella species were also re-
ported (Table 3). 
　Of the isolated pathogens, the susceptibility of E. coli to 
cephalosporin and aminoglycoside was ≥80%. Susceptibi-
lity to 2nd- or 3rd-generation cephalosporin, ciprofloxacin, 
and amikacin showed a relatively high sensitivity rate 
(Table 4). No sequelae such as prostatic abscess or chronic 
prostatitis were found in either group. 
DISCUSSION
ABP, which is diagnosed clinically and from urine culture, 
can be a serious infection. It is usually caused by uropath-
ogens and is associated with fever and chills; rectal, lower 
back, and perineal pain; and urinary urgency, frequency, 
and dysuria. The voided urine shows pyuria, microscopic 
hematuria, and bacteriuria. Prostatic swelling can pro-
duce acute urinary retention. Malaise, arthralgia, and 
myalgia are common symptoms [7,8]. Moreover, prostatic 
massage and transrectal ultrasonography (TRUS) are not 
recommended during the early phase of ABP because it is 
painful for the patient and may lead to bacteremia and sep-
sis [9]. Most physicians also recommend supportive meas-
ures including intravenous hydration and catheter drain-
age if the patient cannot void [10]. 
ABP is a kind of febrile urinary tract infection (UTI), but 
the uropathogens causing UTI do not have correlation with 
ABP. In addition, fever, pain, and lower urinary tract 
symptoms (LUTS) were almost the same in groups 1 and Korean J Urol 2011;52:119-123
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2.
The comparison of the two groups showed that the admis-
sion rate, manipulation rate, and mean pyuria grade were 
lower in group 1, but only the mean length of inpatient 
treatment was statistically significant (Table 1). 
　In this study, it was decided that complaining of fever, 
pain, and LUTS was an admission indication. The mean 
length of treatment with parenteral antibiotics was 
4.8±2.6 days in group 1 and 6.2±2.9 days in group 2.
In the outpatient department after discharge, the mean 
length of treatment for oral antibiotics was 13.9±11.3 days 
in group 1 and 13.7±11.1 days in group 2. On the other hand, 
there was no significant difference in the total length of 
treatment for inpatients after discharge, which were 
18.7±10.5 days and 19.9±11.5 days, respectively. Because 
we used combination therapy for inpatients whose symp-
toms were rather serious, we could get a rapid effect. 
Compared with outpatients who received only single ther-
apy, however, there was not much of a difference in the total 
length of treatment. 
Nowadays, the rate of prostatitis caused by prostate bi-
opsy or catheterization during transurethral surgery is in-
creasing, and these invasive procedures in the lower uri-
nary tract can cause lymphatic or hematogenous spread of 
infection [2]. 
　Of the total 144 patients, 18.8% (27) of the patients had 
a history of prior manipulation of the lower urinary tract, 
mostly prostatic biopsy (51.9%; 14/27) or catheterization 
(22.2%; 6/27). In group 2, E. coli was detected in 28 patients 
(54.9%). A total of 19 patients (54.3%) were reported in the 
group without manipulation and 9 patients (56.3%) were 
detected in the group with manipulation. In this study, no 
specific sequelae were noted after manipulation, which 
was probably caused by exhaustive empirical antibiotics 
before manipulation. In other papers, the prostatic abscess 
rate was reported to be 3.1% and the chronic prostatitis rate 
was reported to be 4.2% [6]. In this study, most of the pa-
tients we followed up for more than 6 months were com-
pletely cured, but 15 patients who were lost to follow-up 
still have a possibility of sequelae. 
　A prostatic abscess may require drainage in addition to 
antimicrobial treatment. It can be drained through the ure-
thra, through the perineum, and through the rectum [11]. 
Occasionally, anaerobes or mixed infections may be re-
sponsible for the abscess. Cultures should always be ob-
tained, and if fungi are suspected, the laboratory should be 
informed. Most treatment regimens should include an 
agent effective against anaerobes. 
　The most serious complication of TRUS-guided biopsy is 
bacterial infection. After biopsy, the reported incidence of 
bacteremia is 16% to 73% and that of bacteriuria is 36% to 
44%. Most often, the bacteria diagnosed in either the urine 
or blood are E. coli [12]. Antibiotic prophylaxis with various 
drug protocols before biopsy has generally been accepted 
to reduce infection-related complications. Several studies 
have shown that quinolone derivatives are effective in low-
ering the incidence of infectious complications [13-15]. 
However, some studies have reported patients developing 
quinolone-resistant infections after prostate biopsy [16, 
17]. Because quinolone has a broad spectrum, the increase 
in the use of these drugs has led to resistance. Ciprofloxacin 
susceptibility was reported in a survey of the antimicrobial 
susceptibility of uropathogens responsible for female acute 
uncomplicated cystitis conducted by the Korean Associa-
tion of Urogenital Tract Infection and Inflammation 
(KAUTII) in 2006 [18]. Such a result probably reflects the 
increase in resistant bacteria owing to the excessive use of 
ciprofloxacin. The guideline for the treatment of urinary 
tract infection of the Infectious Disease Society of America 
(IDSA) published in 1999 does not recommended a specific 
antibiotic for empirical treatment when the local level of 
resistance among E. coli strains exceeds 20%. The IDSA al-
so emphasized that physicians should obtain information 
about local resistance rates [19]. In this context, it is very 
important to select proper antibiotics considering the dis-
tinct characteristics of the area and antibiotics resistance.
In a recent guideline for antibiotic treatment of ABP, the 
administration of cephalosporin or a quinolone alone or in 
combination with an aminoglycoside was recommended 
[20]. This study shows that most commonly, antibiotic com-
bination therapy for ABP includes a cephalosporin and an 
aminoglycoside. For single antibiotic administration, a 
quinolone is most often preferred (Table 2). In group 2, 
there was not much of a difference in antibiotics sensitivity 
between empirical antibiotics, which were used at first, 
and antibiotics that were used according to the results of 
urine culture. In addition, there were no cases of antibiotics 
replacement because of resistance, which proves that em-
pirical treatment is sufficient.
　In conclusion, the results of the present study suggest 
that there is no large difference in clinical symptoms and 
treatment outcome between empirical therapy and ther-
apy considering urine culture results. Therefore, our re-
sults suggest that rapid diagnosis and early use of empiri-
cal broad-spectrum antibiotics play an important role in 
the treatment of ABP. 
Because this study was a retrospective study, there could 
be selection bias. Another limitation is that we did not fol-
low a regular treatment protocol but instead administered 
different antibiotics depending on the physician’s experi-
ence. Furthermore, for better study we should not neglect 
the fact that each physician may have a different view on 
treatment and we should not be biased as we put more im-
portance on combination therapy. 
CONCLUSIONS
Group 1 consisted of 93 patients (64.6%), and there was no 
large difference in clinical symptoms and treatment 
outcome. In the treatment of ABP, the use of empirical anti-
biotics can be expected to have sufficient effects regardless 
of bacterial culture. However, it is hard to determine the 
causative bacteria of ABP by urine culture results alone. Korean J Urol 2011;52:119-123
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